What are the best practices for preventing and managing secondary infections in older adults undergoing Split-Thickness Skin Grafting (SSG), considering their potential comorbidities and compromised immune systems?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Secondary Infection Prevention and Management Post-SSG in Older Adults

In older adults undergoing split-thickness skin grafting, secondary infections are rare but preventable through antimicrobial-impregnated dressings combined with negative-pressure wound therapy, which achieves 100% graft take without infection, even in high-risk elderly patients with multiple comorbidities. 1

Infection Risk Profile in Elderly SSG Patients

The actual infection risk in older adults post-SSG is remarkably low despite theoretical concerns:

  • Only 1 infection occurred among 12 elderly patients (mean age 80.6 years) with severe comorbidities (mean Charlson Comorbidity Index of 7.1), representing an 8% infection rate 2
  • Even in patients with dermatoporosis (chronic cutaneous fragility syndrome), donor sites healed successfully without requiring regrafting 2
  • Zero infections were observed in a study of 25 multi-morbid patients (mean age 71.6 years) with high-risk factors including anticoagulation therapy, anemia, diabetes, and MRSA colonization when using composite collagen dressings 3

Optimal Prevention Strategy

Use antimicrobial-impregnated dressing (0.2% polyhexamethylene biguanide) combined with negative-pressure wound therapy immediately post-grafting:

  • This combination achieved 100% graft take without any infections, hematomas, or seromas in chronic and contaminated wounds 1
  • No secondary interventions were required in any patient using this approach 1
  • The antimicrobial component provides broad-spectrum protection while NPWT ensures adequate immobilization and wound contact 1

Alternative High-Quality Dressing Option

For patients where NPWT is not feasible:

  • Composite collagen/oxidized regenerated cellulose/silver-containing dressings provide excellent outcomes with zero infections observed during first dressing change at 10 days 3
  • This approach achieved complete reepithelization in 10-34 days (mean 17.2 days) in elderly multi-morbid patients 3
  • Particularly effective in patients on anticoagulation therapy, with minimal bleeding complications 3

Donor Site Management Considerations

For elderly patients at highest risk for delayed healing (severe comorbidities, dermatoporosis, poor nutritional status):

  • Consider the "graft back" procedure where an additional split-thickness graft meshed 4:1 covers the donor site 4
  • This converts an open wound to a covered wound, eliminating the secondary wound healing concern entirely 4
  • Zero graft loss or graft infections occurred with this technique, with only 1 non-operative complication in 17 high-risk patients 4

Expected Healing Timeline

Manage expectations appropriately for elderly patients:

  • 50% of elderly morbid patients heal donor sites within the normal 21-day range 2
  • The remaining 50% require 25-97 days for complete healing, but all heal with local wound care alone without regrafting 2
  • Prolonged healing does not equate to infection—it reflects age-related physiological changes 2

Critical Pitfalls to Avoid

  • Do not assume prolonged healing equals infection—elderly patients with dermatoporosis commonly have extended healing times that resolve with conservative management 2
  • Do not delay first dressing change beyond 10 days to allow early infection detection 3
  • Inadequate immobilization and infection are the primary causes of graft failure—address both simultaneously with AMD-NPWT 1
  • Graft thickness should remain between 0.010-0.014 inches even in elderly patients to balance donor site healing with graft success 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.